With no EUA, Covaxin’s launch in US may be delayed

Hyderabad, June 11 (IANS) With the US Food and Drug Administration (US FDA) recommending Ocugen Inc, the US partner of Bharat Biotech, to go for Biologics License Application (BLA) instead of Emergen...

Become a proud member of 1947.com to access this content.